Role of JCV in Crohn's Disease

Role of JCV in CD disease onset and clinical phenotypes

Integrative Multi Omic and Computational Characterization to Identify Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease and Across IBD Populations

Gut Microbial Functions that Impact Multiplex and Non-multiplex Crohn’s Disease Risk

Comparative effectiveness research in Hispanic patients with inflammatory bowel diseases

Colon O glycosylated mucus in the homeostasis of microbiota and host

Understanding Genetic Architecture and Host-microbiome Interactions in Inflammatory Bowel Disease in Under-Represented Minority Populations and in Patients with Unmet Medical Need

Understanding genetic architecture and host-microbiome interactions in Inflammatory bowel disease in under-represented minority populations and in patients with unmet medical need.

Integrating Genomic and Imaging data with scRNAseq to better understand the causes of, and heterogeneity in, Crohn's Disease

Understanding the role of microbiome therapy for delaying IBD onset in genetically predisposed individuals

Characterization of brain white matter abnormalities in patients with Inflammatory Bowel Disease

Genetic and Genomic Approaches to Better Understand the Clinical Heterogeneity in Inflammation Bowel Diseases

Identify Serological Markers Defined Subgroups in CD Patients Using Bigdata Tools

Molecular and Clinical delineation of UC2CD a unique IBD subgroup characterized with high rate of non-response to anti-TNF treatments